Taurel: Lilly won’t cut global sales force

Eli Lilly & Co. Chief Executive Sidney Taurel told CNBC this morning that the Indianapolis-based drug company has no plans to slash its global sales force. Taurel said there has been “some reduction, some reorganization” in Lilly’s sales force, but added, “we don’t see major decreases.”

Pfizer, the world’s largest drugmaker, said recently it would cut 20 percent of its U.S. and European sales forces.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}